Skip to product information
1 of 1

HealthCert Education

Medicinal Cannabis - Auto immune disorders and Inflammatory Conditions

Medicinal Cannabis - Auto immune disorders and Inflammatory Conditions

"Medicinal Cannabis for Autoimmune Disorders and Inflammatory Conditions" offers healthcare professionals an in-depth exploration of cannabinoid-based therapies for chronic pain and inflammation. This course examines the science, evidence, and practical application of medicinal cannabis in managing rheumatoid arthritis and fibromyalgia. Learn how to select appropriate cannabis products, optimise treatment strategies, and integrate cannabinoid therapies into a holistic care model. Equip yourself with evidence-based knowledge and best practices to provide effective, individualised patient care.

time-icon 4.0 hrs EA | 6.0 hrs RP | 0.0 hrs OM
Regular price $195.00
Regular price Sale price $195.00
Sale Sold out

SKU:SHOP-A3CBD

View full details
  • FLEXIBLE TIMING

  • 100% ONLINE

  • accredited Course

  • Expert instructor

This comprehensive course is divided into three detailed units:

Unit 1: Medicinal Cannabis for Rheumatoid Arthritis
Dive into the pathophysiology of rheumatoid arthritis, a chronic autoimmune disorder, and explore the limitations of conventional treatments. This unit examines how cannabinoids can modulate immune responses, reduce inflammation, and alleviate pain. Discover the evidence supporting the use of THC and CBD, and learn about clinical studies showcasing their impact on disease progression and symptom relief. Practical considerations for managing comorbidities like cardiovascular disease and osteoporosis with cannabinoid therapies are also discussed.

Unit 2: Medicinal Cannabis for Fibromyalgia
This unit focuses on fibromyalgia, a complex chronic pain syndrome characterised by widespread pain, fatigue, and mood disturbances. Understand the role of the endocannabinoid system in central sensitisation and the potential for cannabinoids to correct its dysfunction. Evidence from clinical trials highlights the benefits of THC and CBD formulations in improving sleep, reducing pain, and enhancing quality of life. Learn how to tailor treatments to address fibromyalgia's unique challenges and provide holistic care.

Unit 3: Choosing a Medicinal Cannabis Product
Learn to navigate the diverse range of cannabis products to find the right formulation for each patient. This practical unit covers the therapeutic benefits of THC and CBD, dosing protocols, and the importance of starting low and titrating slowly. Discover the advantages of oral and inhaled routes, strategies for managing side effects, and considerations for specific populations, including elderly or anxious patients. A holistic care approach incorporating diet, lifestyle, and supplementary therapies is emphasised to maximise treatment outcomes.

Through case-based learning, evidence reviews, and practical guidance, this course empowers healthcare professionals to confidently incorporate medicinal cannabis into their clinical practice for managing autoimmune and inflammatory conditions.

  1. Determine treatment options for rheumatoid arthritis with medicinal cannabis.
  2. Determine treatment options for fibromyalgia with medicinal cannabis.

This course is designed for GPs and is also suitable for all degree qualified medical professionals.

cpd hours image

CPD Hours:

  • Education hours:  4.0
  • Reviewing performance hours: 6.0
  • Measuring outcome hours:  0.0
cpd hours image

Accreditations:

Royal Australian College of General Practice (RACGP) #414204

Australian College of Rural and Remote Medicine (ACRRM) #30977

cpd hours image

Study Mode:

100% online

cpd hours image

Study duration:

10.0 hrs self-paced

cpd hours image

ABOUT THE PRESENTER

Dr Orit Holtzman

This course is presented by Dr Orit Holtzman.

Orit is a medical doctor with a special interest in functional medicine and medicinal cannabis. She holds a Bachelor of Science in biology and psychology from the University of Tel Aviv, a PhD in neuroscience from the University of NSW and an MBBS from the Sydney Medical School at the University of Sydney. After working in the public hospital system, Dr Holtzman has begun exploring wholistic health solutions and become passionate about utilising medicinal cannabis as a therapeutic agent. She has been prescribing medicinal cannabis for over 5 years and is one of Australia’s most experienced cannabinoid medicine practitioners and educators. She is the Co-founder and Director of Leura Wellness and the co-founder, former President and current Vice-President of the Australian and New Zealand College of Cannabinoid Practitioners.